With trial success in kidney disease, Lilly, Boehringer make case for broader use of diabetes drug
Dive Brief:
Eli Lilly and Boehringer Ingelheim's drug Jardiance kept clinical trial participants with kidney disease from needing dialysis or a transplant, the com...
Continue Reading →
